1. Serum cholinesterase may independently predict prognosis in non-small-cell lung cancer
   Hailiang Ran et al, 2022, BMC Cancer CrossRef
2. A retrospective study of initial dose of sorafenib therapy in Japanese patients with unresectable hepatocellular carcinoma -experiences from a single center
   Haruhiko Takeda et al, 2013, Kanzo CrossRef
3. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification
   Shan Lu et al, 2022, BMC Complementary Medicine and Therapies CrossRef
4. Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer
   Matthias Philipp Fabritius et al, 2021, Journal of Clinical Medicine CrossRef
5. Experience from a real-life cohort: outcome of 606 patients with hepatocellular carcinoma following transarterial chemoembolization
   Martha M. Kirstein et al, 2017, Scandinavian Journal of Gastroenterology CrossRef
6. Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
   Yikai Wang et al, 2023, Scientific Reports CrossRef
7. Preoperative serum cholinesterase as a prognostic factor in patients with colorectal cancer
   Kimihiko Nakamura et al, 2024, Annals of Gastroenterological Surgery CrossRef
8. Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort Study
   Su Jong Yu et al, 2017, Journal of Proteome Research CrossRef
9. Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)
   Hyunsoo Kim et al, 2017, Molecular & Cellular Proteomics CrossRef
10. Effect of treatment with branched‐chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma
    Haruhiko Takeda et al, 2014, Hepatology Research CrossRef
11. Pretreatment MicroRNA Level and Outcome in Sorafenib-treated Hepatocellular Carcinoma
    Benedek Gyöngyösi et al, 2014, Journal of Histochemistry & Cytochemistry CrossRef
12. High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma
    Shintaro Takaki et al, 2019, Molecular and Clinical Oncology CrossRef
13. Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS
    Lena Stockhoff et al, 2022, Hepatology Communications CrossRef
14. Clinical significance of therapy using branched‐chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma
    Hiroki Nishikawa et al, 2014, Hepatology Research CrossRef